Choroid plexus epithelial monolayers - A cell culture model from porcine brain

被引:49
作者
Baehr C. [1 ]
Reichel V. [1 ]
Fricker G. [1 ]
机构
[1] Ruprecht-Karls-University, Institute of Pharmacy and Molecular Biotechnology
来源
Cerebrospinal Fluid Research | / 3卷 / 1期
关键词
Choroid Plexus; Choroid Plexus Epithelium; Apparent Permeability Coefficient; Choroid Plexus Epithelial Cell; Basolateral Chamber;
D O I
10.1186/1743-8454-3-13
中图分类号
学科分类号
摘要
Background: The goal of the present study was to develop an in vitro choroid plexus (CP) epithelial cell culture model for studying transport of protein-mediated drug secretion from blood to cerebrospinal fluid (CSF) and vice versa. Methods: Cells were isolated by mechanical and enzymatic treatment of freshly isolated porcine plexus tissue. Epithelial cell monolayers were grown and CSF secretion and transepithelial resistance were determined. The expression of f-actin as well as the choroid plexus marker protein transthyretin (TTR), were assessed. The expression of the export proteins p-glycoprotein (Pgp, Abcb1) and multidrug resistance protein 1 (Mrp1, Abcc1) was studied by RT-PCR, Western-blot and immunofluorescence techniques and their functional activity was assessed by transport and uptake experiments. Results: Choroid plexus epithelial cells were isolated in high purity and grown to form confluent monolayers. Filter-grown monolayers displayed transendothelial resistance (TEER) values in the range of 100 to 150 Ωcm2. Morphologically, the cells showed the typical net work of f-actin and expressed TTR at a high rate. The cultured cells were able to secrete CSF at a rate of 48.2 ± 4.6 μl/cm2/h over 2-3 hours. The ABC-export protein Mrp1 was expressed in the basolateral (blood-facing) membranes of cell monolayers and intact tissue. P-glycoprotein showed only low expression within the apical (CSF directed) membrane but was located more in sub-apical cell compartments. This finding was paralleled by the lack of directed excretion of p-glycoprotein substrates, verapamil and rhodamine 123. Conclusion: It was demonstrated that CP epithelium can be isolated and cultured, with cells growing into intact monolayers, fully differentiating and with properties resembling the tissue in vivo. Thus, the established primary porcine CP model, allowing investigation of complex transport processes, can be used as a reliable tool for analysis of xenobiotic transport across the blood-cerebrospinal fluid barrier (BCSFB). © 2006 Baehr et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 49 条
[1]  
Spector R., Drug transport in the mammalian central nervous system: Multiple complex systems. A critical analysis and commentary, Pharmacology, 60, pp. 58-73, (2000)
[2]  
Spector R., Johanson C.E., The mammalian choroid plexus, Sci Am, 261, pp. 68-74, (1989)
[3]  
Cserr H.F., Physiology of the choroid plexus, Physiol Rev, 51, pp. 273-311, (1971)
[4]  
Ghersi-Egea J.F., Strazielle N., Brain drug delivery, drug metabolism, and multidrug resistance at the choroid plexus, Microsc Res Tech, 52, pp. 83-88, (2001)
[5]  
el-Bacha R.S., Minn A., Drug metabolizing enzymes in cerebrovascular endothelial cells afford a metabolic protection to the brain, Cell Mol Biol, 45, pp. 15-23, (1999)
[6]  
Choudhuri S., Cherrington N.J., Li N., Klaassen C.D., Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats, Drug Metab Dispos, 31, pp. 1337-1345, (2003)
[7]  
Lee G., Dallas S., Hong M., Bendayan R., Drug transporters in the central nervous system: Brain barriers and brain parenchyma considerations, Pharmacol Rev, 53, pp. 569-596, (2001)
[8]  
Crook R.B., Kasagami H., Prusiner S.B., Culture and characterization of epithelial cells from bovine choroid plexus, J Neurochem, 37, pp. 845-854, (1981)
[9]  
Mayer S.E., Sanders-Bush E., Sodium-dependent antiporters in choroid plexus epithelial cultures from rabbit, J Neurochem, 60, pp. 1308-1316, (1993)
[10]  
Ramanathan V.K., Hui A.C., Brett C.M., Giacomini K.M., Primary cell culture of the rabbit choroid plexus: An experimental system to investigate membrane transport, Pharm Res, 13, pp. 952-956, (1996)